Cellectar Biosciences, Inc. (CLRB) Financials

CLRB Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 21.6 million 34.9 million
2023-06-30 6.5 million 7.0 million
2023-03-31 14.8 million 7.5 million
2022-12-31 21.6 million 6.1 million

CLRB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.7 million 497878
2023-06-30 -7.5 million 419757
2023-03-31 -7.2 million 408206
2022-12-31 -7.5 million 361447

CLRB Net Income

No data available :(

CLRB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 19.0 million - 569013
2023-06-30 5.2 million - 584496
2023-03-31 12.7 million - 599450
2022-12-31 19.9 million - 603828

CLRB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 11.3 million
2023-06-30 11.3 million
2023-03-31 11.3 million
2022-12-31 7.1 million

CLRB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 597282 7.3 million 2.1 million -
2023-06-30 - 6.3 million 2.0 million -
2023-03-31 - 6.7 million 2.1 million -
2022-12-31 117856 5.5 million 2.0 million -

CLRB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 55942
2023-06-30 - 52855
2023-03-31 - 56386
2022-12-31 - 62044

CLRB

Price: $3.42

52 week price:
1.33
4.45

Earnings Per Share: -3.11 USD

P/E Ratio: -1.07

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 27300

Ebitda: -3.4 million

Market Capitalization: 119.7 million

Links: